Tyto Acquisition Corp is 10% Owner at Prevail Therapeutics Inc. (PRVL). They have made 1 open-market trade across 1 company since 2021, most recently 2021-01-22.
CIK 0001836675
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $1.5B since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PRVL | 100 | $2K |
Shares reported on the most recent Form 4, priced at the 2021-01-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PRVL | BUY | 2021-01-22 | 2021-01-22 | $22.50 | $1.5B | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.